People · Operator
Named in public records as an officer, director or promoter · active 2009–2024 · Pharma, Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Click Therapeutics, Inc. | — | Pharma | Series C | $136.7M | $332.4M | 2021 |
| OrsoBio, Inc. | — | Biotechnology | Series C | $124.6M | $340.8M | 2023 |
| Sequoia Pharmaceuticals Inc | — | Pharmaceuticals | Seed | $3.8M | $144.6M | 2009 |
Muzammil Mansuri at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Muzammil Mansuri on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Srinivas Akkaraju | 1 | 10 |
| David Klein | 1 | 10 |
| LEE SHAPIRO | 1 | 10 |
| Matthew Young | 1 | 7 |
| Uri Geiger | 1 | 6 |
| Steve Skolsky | 1 | 4 |
| Cory Freedland | 1 | 3 |
| Gangadhara Ganapati | 1 | 3 |
| JOHN ERICKSON | 1 | 3 |
| Daniel L. Kisner | 1 | 3 |
| Douglas Onsi | 1 | 3 |
| Jeffrey Berkowitz | 1 | 3 |
| Alex Zisson | 1 | 3 |
| Evan Rachlin | 1 | 3 |
| JOHN SADOWSKI | 1 | 2 |
| Randall Stanicky | 1 | 2 |
| Cris De Luca | 1 | 1 |
| Lezrene Cunningham | 1 | 1 |
| Jeff Berkowitz | 1 | 1 |
| Ted Silver | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.